LEE MATLOCK: Open Payments
NPI 1467990820 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,642 in 181 payments from 14 companies in 2025. Trend: 2023 $4,008 · 2024 $4,216 · 2025 $3,642
Food & beverage: $3,585Education: $57
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $734 |
| Amgen Inc. | 51 | $691 |
| UCB, Inc. | 19 | $501 |
| AstraZeneca Pharmaceuticals LP | 20 | $437 |
| PFIZER INC. | 15 | $339 |
| Mallinckrodt Hospital Products Inc. | 7 | $256 |
| Novartis Pharmaceuticals Corporation | 11 | $229 |
| Janssen Biotech, Inc. | 7 | $157 |
| GlaxoSmithKline, LLC. | 6 | $113 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $71 |
Products named: RINVOQ, Bimzelx, SAPHNELO, ENBREL, XELJANZ, ACTHAR, COSENTYX, SKYRIZI.
Industry payments across OK — which companies pay providers there.
